We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Trial Details
Key Eligibility Criteria
600 Participants Needed
Trial Details
Key Eligibility Criteria
350 Participants Needed
Trial Details
Key Eligibility Criteria
176 Participants Needed
Trial Details
Key Eligibility Criteria
399 Participants Needed
Trial Details
Key Eligibility Criteria
16000 Participants Needed
Trial Details
Key Eligibility Criteria
7297 Participants Needed
Trial Details
Key Eligibility Criteria
800 Participants Needed
Trial Details
Key Eligibility Criteria
1550 Participants Needed
Trial Details
Key Eligibility Criteria
2196 Participants Needed
Trial Details
Key Eligibility Criteria
511 Participants Needed
Trial Details
Key Eligibility Criteria
900 Participants Needed
Trial Details
Key Eligibility Criteria
858 Participants Needed
Trial Details
Key Eligibility Criteria
94 Participants Needed
Trial Details
Key Eligibility Criteria
741 Participants Needed
Trial Details
Key Eligibility Criteria
80 Participants Needed
Trial Details
Key Eligibility Criteria
390 Participants Needed
Trial Details
Key Eligibility Criteria
864 Participants Needed
Trial Details
Key Eligibility Criteria
390 Participants Needed
Trial Details
Key Eligibility Criteria
1395 Participants Needed
Trial Details
Key Eligibility Criteria
225 Participants Needed
Trial Details
Key Eligibility Criteria
1667 Participants Needed
Trial Details
Key Eligibility Criteria
750 Participants Needed
Trial Details
Key Eligibility Criteria
122 Participants Needed
Trial Details
Key Eligibility Criteria
1000 Participants Needed
Trial Details
Key Eligibility Criteria
404 Participants Needed
Trial Details
Key Eligibility Criteria
350 Participants Needed
Trial Details
Key Eligibility Criteria
220 Participants Needed
Trial Details
Key Eligibility Criteria
466 Participants Needed
Trial Details
Key Eligibility Criteria
274 Participants Needed
Trial Details
Key Eligibility Criteria
905 Participants Needed